# Navam Capital

> Navam Capital is a VC fund backing Manufacturing and Health Care. See 28 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Calcutta Bagh Bazar, India
- Total investments: 28
- Last investment: Apr 2026
- Lead investor: 14%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/navam-capital
- X (Twitter): http://twitter.com/NavamCapital
- Website: http://www.navamcapital.com

Navam Capital is an India-based venture capital firm focused on making seed and early-stage investments in Energy, Technology and Health Care.

## Contacts

5 contacts available for Navam Capital. Shizune tracks 2 team members at Navam Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/navam-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $120k–$5.4M |
| Series A | $1.9M–$26M |
| Series B | $8M–$28M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 5 | 18% |
| Health Care | 4 | 14% |
| Biotechnology | 4 | 14% |
| Artificial Intelligence | 4 | 14% |
| Robotics | 3 | 11% |

50 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 10 | 36% |
| Series A | 6 | 21% |
| Series B | 4 | 14% |
| Venture - Series Unknown | 2 | 7% |
| Series E | 1 | 4% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| India | 17 | 61% |
| United States | 2 | 7% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Carl Barrelet | Venture Partner | 0 | https://shizune.co/investors/profile/carl-barrelet |
| Rajeev Mantri | Executive Director & Founder | 2 | https://shizune.co/investors/profile/rajeev-mantri |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Morphing Machines | Morphing Machines is on a mission to create an exciting new range of silicon-centric solutions for compute-intensive applications. Leveraging the path-breaking patent-pending REDEFINE Reconfigurable Massively Parallel Processor SoC platform technology, a variety of high-performance silicon solutions for various application domains have beendeveloped at Morphing Machines in the areas of cryptography, data security, avionics, high-definition image and video processing, numerical computation, neural networks and deep learning, and other areas.REDEFINE based solutions deliver a unique combination of high performance and flexibility not available from other technologies offered by global players. REDEFINE technology enables ASIC-like high performance at an affordable NRE cost for a much wider range of compute-intensive applications than has ever been possible before. Advanced compiler toolchain and runtime software support is an integral part of the REDEFINE offerings. | $4.5M | Series A | Apr 27, 2026 |  |
| GalaxEye | GalaxEye enables businesses to make better Decisions & perform operations efficiently via Space Technology. | $4.8M | Series A | Mar 12, 2026 |  |
| e-TRNL Energy | A revolutionary cell design and manufacturing concept that eliminates battery cell heating at the source, allowing us to realize the full potential of fast charging while avoiding cell degradation. | $3M | Seed | Feb 13, 2026 |  |
| Unbox Robotics | Unbox Robotics's 1st product is the World's 1st of its kind patent pending AI-powered parcel sorting robotic system that gets installed 10X faster, saves 50+% space and improves productivity by more than 5X. And the system needs 50% fewer robots than that of the competition! |  | Secondary Market | Jan 20, 2026 |  |
| Unbox Robotics | Unbox Robotics's 1st product is the World's 1st of its kind patent pending AI-powered parcel sorting robotic system that gets installed 10X faster, saves 50+% space and improves productivity by more than 5X. And the system needs 50% fewer robots than that of the competition! | $28M | Series B | Jan 20, 2026 |  |
| Morphing Machines | Morphing Machines is on a mission to create an exciting new range of silicon-centric solutions for compute-intensive applications. Leveraging the path-breaking patent-pending REDEFINE Reconfigurable Massively Parallel Processor SoC platform technology, a variety of high-performance silicon solutions for various application domains have beendeveloped at Morphing Machines in the areas of cryptography, data security, avionics, high-definition image and video processing, numerical computation, neural networks and deep learning, and other areas.REDEFINE based solutions deliver a unique combination of high performance and flexibility not available from other technologies offered by global players. REDEFINE technology enables ASIC-like high performance at an affordable NRE cost for a much wider range of compute-intensive applications than has ever been possible before. Advanced compiler toolchain and runtime software support is an integral part of the REDEFINE offerings. | $4.3M | Series A | Oct 06, 2025 |  |
| Frinks AI | Frinks AI is an AI Software Development firm offering Effective, Efficient and Reliable Quality Control. | $5.4M | Seed | May 27, 2025 |  |
| Vayudh | Vayudh's aim is to create next-generation nanodrones and swarming technologies for modern defense and security applications. | $10M | Venture - Series Unknown | Apr 22, 2025 |  |
| GalaxEye | GalaxEye enables businesses to make better Decisions & perform operations efficiently via Space Technology. | $3.5M | Series A | Nov 06, 2024 |  |
| Alyssum Therapeutics | Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells. | $26M | Series A | Oct 23, 2024 |  |

10 of 28 investments shown.

## Co-investors
- [Speciale Invest](https://shizune.co/investors/profile/speciale-invest) — VC Fund, 7 deals together
- [Anicut Capital](https://shizune.co/investors/profile/anicut-capital) — VC Fund, 5 deals together
- [Aarin Capital](https://shizune.co/investors/profile/aarin-capital) — VC Fund, 4 deals together
- [3one4 Capital](https://shizune.co/investors/profile/3one4) — VC Fund, 3 deals together
- [Faad Network](https://shizune.co/investors/profile/faad-network) — VC Fund, 3 deals together
- [Force Ventures](https://shizune.co/investors/profile/force-ventures-3142) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Titan Capital](https://shizune.co/investors/profile/titan-capital) — VC Fund
- [Inflection Point Ventures](https://shizune.co/investors/profile/inflection-point-ventures-d275) — VC Fund
- [Blume Ventures](https://shizune.co/investors/profile/blume-ventures) — VC Fund

## Featured in investor lists
- [Hardware VC Funds in India](https://shizune.co/investors/hardware-vc-funds-india)
- [Biotech Investors in India](https://shizune.co/investors/biotech-investors-india)
- [Biotech VC Funds in India](https://shizune.co/investors/biotech-vc-funds-india)
- [Biotechnology Investors in India](https://shizune.co/investors/biotechnology-investors-india)
- [Biotechnology VC Funds in India](https://shizune.co/investors/biotechnology-vc-funds-india)
- [Medical Device Investors in India](https://shizune.co/investors/medical-device-investors-india)

## FAQ

### What does Navam Capital invest in?

Navam Capital invests primarily in Manufacturing, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 28 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Navam Capital's check size?

Navam Capital typically joins rounds of $120k–$5.4M at Seed, $1.9M–$26M at Series A and $8M–$28M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Navam Capital participates in.

### How do I contact Navam Capital?

Public channels for Navam Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Navam Capital?

The team at Navam Capital includes Carl Barrelet (Venture Partner) and Rajeev Mantri (Executive Director & Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co